Whole-pelvis or bladder-only chemoradiation for lymph node–negative invasive bladder cancer: single-institution experience
MA Tunio, A Hashmi, A Qayyum, R Mohsin… - International Journal of …, 2012 - Elsevier
PURPOSE: Whole-pelvis (WP) concurrent chemoradiation (CCRT) is the standard bladder
preserving option for patients with invasive bladder cancer. The standard practice is to treat …
preserving option for patients with invasive bladder cancer. The standard practice is to treat …
Is thyroid gland an organ at risk in breast cancer patients treated with locoregional radiotherapy? Results of a pilot study
MA Tunio, M Al Asiri, Y Bayoumi… - Journal of cancer …, 2015 - journals.lww.com
Background: Aim was to evaluate the dose distribution within the thyroid gland its association
with hypothyroidism in breast cancer (BC) patients receiving supraclavicular (SC) radiation …
with hypothyroidism in breast cancer (BC) patients receiving supraclavicular (SC) radiation …
Primary squamous cell carcinoma of thyroid: a case report and review of literature
MA Tunio, M Al Asiri, M Fagih, R Akasha - Head & neck oncology, 2012 - Springer
Background Thyroid gland lacks squamous epithelium (except in some rare situations like
embroyonic remnants or in inflammatory processes); for that reason the primary squamous …
embroyonic remnants or in inflammatory processes); for that reason the primary squamous …
Nasolacrimal duct obstruction following radioactive iodine 131 therapy in differentiated thyroid cancers: review of 19 cases
KH Al-Qahtani, M Al Asiri, MA Tunio… - Clinical …, 2014 - Taylor & Francis
Background Radioactive iodine 131 ( 131 I) therapy has long been used in the treatment of
differentiated thyroid cancers (DTC). While salivary and lacrimal glandular complications …
differentiated thyroid cancers (DTC). While salivary and lacrimal glandular complications …
Is extended-field concurrent chemoradiation an option for radiologic negative paraaortic lymph node, locally advanced cervical cancer?
MA Asiri, MA Tunio, R Mohamed… - Cancer management …, 2014 - Taylor & Francis
Background The aim was to evaluate whether extended-field concurrent chemoradiation (EF-CCRT)
leads to results better than those obtained by standard whole-pelvis concurrent …
leads to results better than those obtained by standard whole-pelvis concurrent …
Adjuvant Radioactive iodine 131 ablation in papillary microcarcinoma of thyroid: Saudi Arabian experience
KH Al-Qahtani, M Al Asiri, MA Tunio… - … -Head & Neck …, 2015 - journals.sagepub.com
Background Papillary Microcarcinoma (PMC) of thyroid is a rare type of differentiated thyroid
cancer (DTC), which according to the World Health Organization measures 1.0 cm or less. …
cancer (DTC), which according to the World Health Organization measures 1.0 cm or less. …
[HTML][HTML] Duodenal metastasis from lung adenocarcinoma: A rare cause of melena
EF AlSaeed, MA Tunio, K AlSayari, S AlDandan… - International Journal of …, 2015 - Elsevier
Introduction We report a rare case of duodenal metastasis from primary lung adenocarcinoma
presented with history of melena and weight loss. Presentation of case A 52-year-old …
presented with history of melena and weight loss. Presentation of case A 52-year-old …
Changes in pulmonary function tests in breast carcinoma patients treated with locoregional post-mastectomy radiotherapy: results of a pilot study
EF AlSaeed, FK Balaraj, MA Tunio - Breast Cancer: Targets and …, 2017 - Taylor & Francis
Background The aim of present pilot study was to evaluate the changes in pulmonary function
tests (PFTs) after locoregional post-mastectomy radiotherapy (PMRT) in breast cancer …
tests (PFTs) after locoregional post-mastectomy radiotherapy (PMRT) in breast cancer …
Clinicopathological features and treatment outcomes of the rare, salivary duct carcinoma of parotid gland
KH Al-Qahtani, MA Tunio, Y Bayoumi… - … -Head & Neck …, 2016 - journals.sagepub.com
Background Salivary ductal carcinoma (SDC) of parotid gland is a rare and aggressive entity;
accounting for 1–3 % of all malignant salivary gland tumors, 0.2 % of epithelial salivary …
accounting for 1–3 % of all malignant salivary gland tumors, 0.2 % of epithelial salivary …
[HTML][HTML] Pancreas as delayed site of metastasis from papillary thyroid carcinoma
MA Tunio, M AlAsiri, K Riaz… - Case Reports in …, 2013 - hindawi.com
Introduction. Follicular variant (FV) papillary thyroid carcinoma (PTC) has aggressive biologic
behavior as compared to classic variant (CV) of PTC and frequently metastasizes to the …
behavior as compared to classic variant (CV) of PTC and frequently metastasizes to the …
